This grant is for advancing translational and clinical research, including clinical trials, focused on understanding drug mechanisms, response, and safety. Its primary aim is to enhance knowledge in pediatric populations across various developmental stages, and in pregnant women and the developing fetus. The overarching goal is to improve the safety and effectiveness of existing medications, foster the development of novel drugs, and promote safer use of current treatments. This initiative seeks to facilitate tailored therapeutic approaches for these specific and vulnerable patient groups, addressing their unique clinical needs. The research will contribute to better drug therapies and patient outcomes.
Opportunity ID: 239295
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-13-311 |
| Funding Opportunity Title: | Translational Research in Pediatric and Obstetric Pharmacology and Therapeutics (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 05, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 16, 2016 |
| Current Closing Date for Applications: | Aug 16, 2016 |
| Archive Date: | Sep 16, 2016 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments State governments For profit organizations other than small businesses Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education City or township governments Small businesses Special district governments Private institutions of higher education Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in pregnant women and the developing fetus. The overall goals of the FOA are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-13-311.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.865 | FORMS-C | Forms-C | PKG00182453 | Oct 19, 2013 | Jun 07, 2016 | View |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00223982 | Jul 16, 2016 | Aug 16, 2016 | View |
Package 1
Mandatory forms
239295 RR_SF424_2_0-2.0.pdf
239295 PHS398_ResearchPlan_2_0-2.0.pdf
239295 PHS398_CoverPageSupplement_2_0-2.0.pdf
239295 RR_KeyPersonExpanded_2_0-2.0.pdf
239295 RR_OtherProjectInfo_1_3-1.3.pdf
239295 PerformanceSite_2_0-2.0.pdf
Optional forms
239295 RR_SubawardBudget30_1_3-1.3.pdf
239295 PlannedReport-1.0.pdf
239295 PHS398_CumulativeInclusionReport-1.0.pdf
239295 PHS398_ModularBudget_1_2-1.2.pdf
239295 RR_Budget_1_3-1.3.pdf
Package 2
Mandatory forms
239295 RR_SF424_2_0-2.0.pdf
239295 PHS398_CoverPageSupplement_3_0-3.0.pdf
239295 RR_OtherProjectInfo_1_3-1.3.pdf
239295 PerformanceSite_2_0-2.0.pdf
239295 RR_KeyPersonExpanded_2_0-2.0.pdf
239295 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
239295 RR_Budget_1_3-1.3.pdf
239295 RR_SubawardBudget30_1_3-1.3.pdf
239295 PHS398_ModularBudget_1_2-1.2.pdf
239295 PHS_Inclusion_Enrollment_Report-1.0.pdf
239295 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
